glp 1 and gip dual agonist TrimRX GIP (Gastric Inhibitory Polypeptide) Assay
Description
Market Size & Forecast Major Players Companies such as Novo Nordisk (DK), Eli Lilly (US), Sanofi (FR), Boehringer Ingelheim (DE), AstraZeneca (GB), Merck & Co
The combination of high disease burden and growing awareness of effective treatments drives demand for GLP-1 receptor agonists
The patients studied by Chen et al
Vendors making this claim are either misinformed or deliberately misleading
GLP-1 = glucagon-like peptide-1
P for heterogeneity = .81] [69]
